retatrutide 2025 trial results VisualAbstract: reduces body weight by 17.5% in patients with obesity Looking forward to when #retatrutide's

Prescription GLP-1 medications are usually taken once weekly, following medical guidance (15,16,17)

This gives the pill time to be absorbed

IP assets that may be licensed or sold separately a new indications method-of-use portfolio, a device patent family, a manufacturing process patent are harder to transact when embedded in a CIP family that is legally entangled with the parent through shared prosecution history, terminal disclaimers, and dual priority date dependencies

Slow progress often feels less glamorous, but its far more realisticand far more likely to last

Mozes FE, Lee JA, Vali Y, Alzoubi O, Staufer K, Trauner M, et al

Comparing the two is like comparing a candle to a floodlight